Page 37 - Read Online
P. 37
Page 10 of 16 Sugarbaker. J Cancer Metastasis Treat 2018;4:7 I http://dx.doi.org/10.20517/2394-4722.2017.67
[7]
Figure 8. Omental bursa peritonectomy (From Sugarbaker et al. with permission)
Figure 9. Pelvic peritonectomy (From Sugarbaker et al. with permission)
[7]
Operative interventions were total gastrectomy (n = 94), subtotal colectomy (n = 68), small bowel resection
(n = 44). Left and right subdiaphragmatic peritonectomy and pelvic peritonectomy was complete in 44, 31,
and 61 patients, respectively. In 102 (67.7%) patients, of the 152 cytoreductions a complete cytoreduction was
recorded.
Figure 5 demonstrates survival of the 194 patients. Median survival was 18 months for all 194 patients. For
those who had received surgical intervention, median survival was 15.8 months vs. 9.7 months for patients
who did not have an operation. There was a significant survival difference (P < 0.001, Z = 20.98) between
patients who underwent operative intervention vs. those who did not. There was a higher median survival of
20.5 months for patients who received a complete cytoreduction vs. 10.9 months for those who did not have a
complete cytoreduction. There was no difference between primary and recurrent disease after cytoreduction
